Acceso gestor editorial. Non-alcoholic fatty liver disease NAFLD is indisputably the most widespread liver disease worldwide, leading to a significant increase in patient morbidity, mortality, and health care utilization.
The gut microbiota and its genome microbiome have emerged as a novel modulator of the immunometabolic processes that NAFLD implies, but microbiota-targeted interventions have resulted both astounding and at the same time unsuccessful. Here, a better understanding of the major intestinal microbial factors with a detrimental or preventive role in NAFLD, and of the dynamic interplay between gut microbiome and host factors, appears crucial in defining the exposome for the prevention and treatment of NAFLD and associated diseases such as metabolic syndrome, type-2 diabetes, and obesity.
Palabras Clave: Biomarkers. Global health.
Phenotype s. Ballesteros Pomar.
ES EN. Texto a Buscar Texto a Buscar. Resumen PDF.
Programa Modernización Nutrición Hospitalaria ESSALUD
Publicado: Licencia creative commons: Open Access bajo la licencia Creative Commons 4. Ahora no Aceptar. Editado en Madrid por:.